221 related articles for article (PubMed ID: 9691456)
1. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67.
Vaishnav VV; Bacon BE; O'Neill M; Cherniak R
Carbohydr Res; 1998 Jan; 306(1-2):315-30. PubMed ID: 9691456
[TBL] [Abstract][Full Text] [Related]
2. Galactoxylomannans of Cryptococcus neoformans.
James PG; Cherniak R
Infect Immun; 1992 Mar; 60(3):1084-8. PubMed ID: 1541523
[TBL] [Abstract][Full Text] [Related]
3. An extracellular galactoxylomannan of acapsular Cryptococcus laurentii mutant.
Capek P; Dudíková J; Matulová M; Kolarova N
Int J Biol Macromol; 2008 Nov; 43(4):394-6. PubMed ID: 18706925
[TBL] [Abstract][Full Text] [Related]
4. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
Turner SH; Cherniak R
Carbohydr Res; 1991 Apr; 211(1):103-16. PubMed ID: 1773425
[TBL] [Abstract][Full Text] [Related]
5. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A
Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901
[TBL] [Abstract][Full Text] [Related]
6. Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
Cherniak R; Morris LC; Meyer SA
Carbohydr Res; 1992 Mar; 225(2):331-7. PubMed ID: 1643653
[No Abstract] [Full Text] [Related]
7. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
[TBL] [Abstract][Full Text] [Related]
8. Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.
De Jesus M; Chow SK; Cordero RJ; Frases S; Casadevall A
Eukaryot Cell; 2010 Jul; 9(7):1018-28. PubMed ID: 20061411
[TBL] [Abstract][Full Text] [Related]
9. Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography-mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy.
Cherniak R; Morris LC; Turner SH
Carbohydr Res; 1992 Jan; 223():263-9. PubMed ID: 1596924
[No Abstract] [Full Text] [Related]
10. The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid.
Heiss C; Klutts JS; Wang Z; Doering TL; Azadi P
Carbohydr Res; 2009 May; 344(7):915-20. PubMed ID: 19345342
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the 6-O-acetylated lipoglucuronomannogalactan a novel Cryptococcus neoformans cell wall polysaccharide.
Previato JO; Vinogradov E; Silva MAE; Oliveira PAV; Fonseca LM; Maes E; Mendonça-Previato L
Carbohydr Res; 2019 Mar; 475():1-10. PubMed ID: 30742969
[TBL] [Abstract][Full Text] [Related]
12. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.
Grijpstra J; Gerwig GJ; Wösten H; Kamerling JP; de Cock H
Eukaryot Cell; 2009 Aug; 8(8):1165-73. PubMed ID: 19542308
[TBL] [Abstract][Full Text] [Related]
13. Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans.
Gutierrez AL; Farage L; Melo MN; Mohana-Borges RS; Guerardel Y; Coddeville B; Wieruszeski JM; Mendonça-Previato L; Previato JO
Glycobiology; 2007 Jun; 17(6):1-11C. PubMed ID: 17369287
[TBL] [Abstract][Full Text] [Related]
14. Structural studies of a cell wall polysaccharide of Trichosporon asahii containing antigen II.
Ichikawa T; Nishikawa A; Ikeda R; Shinoda T
Eur J Biochem; 2001 Oct; 268(19):5098-106. PubMed ID: 11589701
[TBL] [Abstract][Full Text] [Related]
15. Cell-wall glucans of Cryptococcus neoformans Cap 67.
James PG; Cherniak R; Jones RG; Stortz CA; Reiss E
Carbohydr Res; 1990 Apr; 198(1):23-38. PubMed ID: 2191777
[TBL] [Abstract][Full Text] [Related]
16. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy.
Besra GS; Khoo KH; McNeil MR; Dell A; Morris HR; Brennan PJ
Biochemistry; 1995 Apr; 34(13):4257-66. PubMed ID: 7703239
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.
Ikeda R; Matsuyama H; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1991; 35(2):125-38. PubMed ID: 1886490
[TBL] [Abstract][Full Text] [Related]
18. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.
Villena SN; Pinheiro RO; Pinheiro CS; Nunes MP; Takiya CM; DosReis GA; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
Cell Microbiol; 2008 Jun; 10(6):1274-85. PubMed ID: 18284419
[TBL] [Abstract][Full Text] [Related]
19. Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes.
Reiss E; Huppert M; Cherniak R
Curr Top Med Mycol; 1985; 1():172-207. PubMed ID: 3916766
[TBL] [Abstract][Full Text] [Related]
20. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
Ikeda R; Maeda T
Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
